367 related articles for article (PubMed ID: 32574766)
1. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
3. Urinary exosomes: Potential biomarkers for diabetic nephropathy.
Sinha N; Kumar V; Puri V; Nada R; Rastogi A; Jha V; Puri S
Nephrology (Carlton); 2020 Dec; 25(12):881-887. PubMed ID: 32323449
[TBL] [Abstract][Full Text] [Related]
4. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
5. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
[TBL] [Abstract][Full Text] [Related]
6. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
8. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
9. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
10. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
[TBL] [Abstract][Full Text] [Related]
11. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
Van JA; Scholey JW; Konvalinka A
J Am Soc Nephrol; 2017 Apr; 28(4):1050-1061. PubMed ID: 28159781
[TBL] [Abstract][Full Text] [Related]
12. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
[TBL] [Abstract][Full Text] [Related]
14. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
17. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
Currie G; Delles C
Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
[TBL] [Abstract][Full Text] [Related]
19. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
[TBL] [Abstract][Full Text] [Related]
20. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
